CARTANA
DEAD

Serial Number

79296355

Owner

CartaNA AB

Filing Date

Aug 19, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CARTANA Trademark

Serial Number: 79296355

CARTANA is a trademark filed by CartaNA AB on August 19, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

CartaNA AB

Nobels väg 16

Entity Type: 09

Trademark Details

Filing Date

August 19, 2020

Registration Date

Not Registered

Goods & Services

Apparatus and instruments for scientific and diagnostic use; apparatus and instruments used for in situ RNA sequencing, RNA transcription profiling, detection of RNA in tissue samples, microRNA expression profiling, detection of single nucleotide polymorphisms, analysis of functional pathways gene sets, diagnostics, companion diagnostics; appartus and instruments for detection of gene mutation for clinical, oncology, and hematology diagnostics; apparatus, instruments and software used in scientific analysis, RNA expression profiling, detection of RNA, image analysis and cell segmentation for research and diagnostic use; microfluidic instruments for non-medical use; apparatus, instruments and software used in scientific analysis, RNA expression profiling and detection of RNA for research and diagnostic use

Diagnostic reagents for medical use in the field of cancer; diagnostic reagents for clinical or medical laboratory use, namely, for in situ RNA sequencing, RNA transcription profiling, detection of RNA in tissue samples, microRNA expression profiling, detection of polymorphisms, analysis of functional pathway gene sets, diagnostics, companion diagnostics; diagnostic reagents for detection of gene mutation for clinical, oncology, and hematology diagnostics; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily of reagents, slides, solid matrix materials, microfluidic devices sold as a unit; medical diagnostic test kits for detecting pathogens, comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit; medical diagnostic reagents for in situ RNA sequencing, RNA transcription profiling, detection of RNA in tissue samples, microRNA expression profiling, detection of polymorphisms, analysis of functional pathway gene sets, diagnostics, companion diagnostics; reagents for microfluidic instruments for medical use; kits for research use, diagnostics use and drug development, namely, oligonucleotides, reagent buffers, enzymes, detection solutions and fluorophores; kits for research use, diagnostics use and drug development, namely, oligonucleotides, reagent buffers, enzymes, detection solutions and fluorophores

Chemicals used in scientific analysis, research, diagnostics and industrial use; chemicals for in situ RNA sequencing, RNA transcription profiling, detection of RNA in tissue samples, microRNA expression profiling, detection of polymorphisms, analysis of functional pathway gene sets, diagnostics, companion diagnostics; chemicals kits including oligonucleotides, reagent buffers, enzymes, detection solutions, fluorophores for research and diagnostics use and drug development purpose; reagents for microfluidic instruments for non-medical use

Medical services; medical diagnostic services; veterinary services; veterinary diagnostic services

Apparatus and instruments used for in situ RNA sequencing, RNA transcription profiling, detection of RNA in tissue samples, microRNA expression profiling, detection of single nucleotide polymorphisms, analysis of functional pathways gene sets, diagnostics, companion diagnostics for medical use; microfluidic instruments for medical use

Research, development and diagnostics services for others regarding in situ RNA sequencing, RNA transcription profiling, detection of RNA in tissue samples, microRNA expression profiling, detection of single nucleotide polymorphisms, analysis of functional pathways gene sets; drug development; diagnostic and companion diagnostic development; data science (biostatistics) services; laboratory biomarker analysis services and related data analysis; image analysis and cell segmentation services; medical and scientific research

Filing History

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Apr 14, 2021 LIMN
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Mar 28, 2021 DENA
DEATH OF INTERNATIONAL REGISTRATION
Mar 27, 2021 DETH
LIMITATION OF GOODS RECEIVED FROM IB
Mar 20, 2021 LIMG
REFUSAL PROCESSED BY IB
Jan 30, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 8, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jan 8, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 23, 2020 RFCR
NON-FINAL ACTION WRITTEN
Dec 22, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 16, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 30, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 22, 2020 REPR